Skip to main content
S&P 5007,637.76+1.14%DOW51,778.04+0.61%NASDAQ26,418.30+1.69%BTC$76,416.00+0.10%ETH$2,442.29+0.95%GOLD$4,397.70-0.05%OIL$100.86-1.03%
Smart Investors Daily
AI

NASDAQ · AIMD

Ainos, Inc.

Healthcare · Biotechnology

$1.49

Up+$0.11 (+7.97%)

Updated Sep 18, 2026, 2:16 AM

SID Score

2.8/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
7.91M
P/E ratio
-0.5
Dividend yield
0.00%
52-week range
$1.26 – $4.44
Volume
31.85K
Avg. volume
660.22K

Price performance

AIMD price history

1M range · 0 trading sessions · Daily adjusted prices

AIMD does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest AIMD news

The latest Smart Investors Daily articles mentioning AIMD.

Stock researchCompany · Overview

AIMD research

Overview

Company profile and research snapshot.

Company profile

Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 9, 2026

Ainos Secures Three Japanese Robotics Patents, Advancing Chemical Perception for the Physical AI Era

New patents cover electronic nose integration with robotics, expanding Ainos' portfolio of 124 patent assets worldwide across chips, sensing architectures, chemical molecules and real-world applicationsHOUSTON, TX / ACCESS Newswire / September 9, 2026 / (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company") today announced that it has secured three new Japanese patents covering AI Nose technologies and their integration with robotic systems.AI Is Moving Into the Physical World - and Machines Nee

Benzinga · Aug 17, 2026

Ainos Rolls Out AI Nose Platform

Ainos, Inc. (NASDAQ:AIMD, AIMDW)) ("Ainos" or the "Company"), a pioneer in AI-powered Chemical Intelligence, today announced the next generation of its AI Nose platform, featuring comprehensive upgrades

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By